Pfizer sticks to forecast after first-quarter profit boost from Ibrance [Reuters]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Reuters
Pfizer sticks to forecast after first-quarter profit boost from Ibrance (Reuters) - Pfizer Inc on Tuesday reiterated its 2020 forecast after posting a quarterly profit that exceeded estimates on higher sales of breast cancer drug Ibrance and blood thinner Eliquis. The largest U.S. drugmaker said it saw an increase in demand for its pneumonia vaccine Prevnar, some anti-infective products as well as certain sterile injectable products used in the treatment of severely sick COVID-19 patients. Overall Prevnar sales, however, fell 2.4%. The company’s shares rose 2% in premarket trading after it said it continues to see full-year earnings in the range $2.82 to $2.92 as it expects an improvement in disrupted business activity in the second half of the year. With a collaboration with Germany’s BioNTech, Pfizer is among the many drugmakers in the race to develop a vaccine to end the COVID-19 pandemic. The companies’ German trial is among the four studies worldwide to begin human testing of the
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer: The Market Is Still Wrong About It [Seeking Alpha]Seeking Alpha
- FDA chief claims Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- FDA chief says Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Jim Cramer on Pfizer: “I Would Hold on to It” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website